VIVAPRIME ULTIMAN
Natural health product licensed in Canada
- Other names
- West Coast Ayurveda Vita-Man
- Licence holder
- Mission Vivacare Inc.
- NPN or DIN-HM
- 80031430
- Status
- Active licence
- Licence date
- 13 April 2012
- Revision date
- 20 June 2013
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 125 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 10 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 100 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Potassium: up to 100 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Phosphate de calcium, dibasique | 20 mg | 80,000 µg |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 16.75 mg AT | Not calculated |
| Acide DL-alpha lipoÏque | 25 mg | Not calculated |
| Phyllanthus emblica Source : Fruit extract Extraction ratio : 5:1 Dry plant equivalent : 125 mg | 25 mg | Not calculated |
| Chrome Source : Produit de chélation chromique et de protéine végétale hydrolysée (PVH) | 31.25 mcg | 125 µg |
| Riboflavine Source : Riboflavine | 12.5 mg | 50,000 µg |
| Vitamine D Source : Cholécalciférol Potency : 100 UI | 2.5 mcg | 10 µg |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 25 mcg | 100 µg |
| Potassium Source : Chlorure de potassium | 25 mg | 100,000 µg |
| Acide pantothénique Source : D-Pantothénate de calcium | 15 mg | 60,000 µg |
| Niacine Source : Acide nicotinique | 18.75 mg | Not calculated |
| Phosphore Source : Phosphate dicalcique | 26.5 mg | 106,000 µg |
| Lécithine Source : Huile de soja | 6.25 mg | Not calculated |
| (3R,3'R)-Dihydroxy-beta-carotene Source : Oléorésine de tagetes erecta | 0.3 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 12.5 mcg | 50 µg |
| Bacopa monnieri Source : Herb extract Extraction ratio : 30:1 Dry plant equivalent : 375 mg Potency : 50 % Bacosides | 12.5 mg | Not calculated |
| Panax ginseng Source : Root extract (standardised) Extraction ratio : 25:1 Dry plant equivalent : 187.5 mg Potency : 60 % ginsenosides | 7.5 mg | Not calculated |
| Folate Source : Folate | 100 mcg | Not calculated |
| Inositol Source : Maïs | 2.5 mg | Not calculated |
Non-medicinal ingredients
gomme de guar, cellulose, Glycérine, Microcrystalline cellulose, Croscarmellose de sodium, Stéarate de magnésium, Hydroxypropylméthylcellulose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 1 Comprimé | 3 Tous les jours |
| Adultes de sexe masculin | Not specified | 2 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Vitamin, mineral, and other factors supplement for the maintenance of good health. Helps the body to metabolize fats and proteins. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing. An antioxidant for the maintenance of good health. Helps to produce red blood cells. Helps in the development and maintenance of bones and teeth, (especially in childhood, adolescence and young adulthood). Helps to maintain proper muscle function. Helps to maintain eyesight, skin, membranes and immune function. Helps in the development and maintenance of night vision. Helps to maintain healthy skin.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80031430
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2013. Photograph the packaging to check whether it has changed. Photograph the packaging